SPONSOR
Qianfoshan Hospital
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 4, Phase 3
Conditions studied: Chronic Kidney DiseasesRenal TransplantationPostoperative Pain, AcuteHemodynamicsTotal Knee Arthroplasty (TKA)Locally Advanced Non-Small Cell Lung CancerMetastatic NSCLCAllergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Chronic Kidney Diseases, Renal Transplantation, Postoperative Pain, Acute, Hemodynamics.
The trial portfolio spans Phase 1, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qianfoshan Hospital
How many clinical trials has Qianfoshan Hospital sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Qianfoshan Hospital, of which 6 are actively recruiting participants. These trials cover conditions including Chronic Kidney Diseases, Renal Transplantation, Postoperative Pain, Acute. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qianfoshan Hospital research focus on?
Qianfoshan Hospital clinical trials span Chronic Kidney Diseases, Renal Transplantation, Postoperative Pain, Acute, Hemodynamics, Total Knee Arthroplasty (TKA), and additional conditions. The research pipeline includes Phase 1, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qianfoshan Hospital clinical trial?
To participate in a Qianfoshan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qianfoshan Hospital trials with current recruitment status updated daily.
Clinical Trials by Qianfoshan Hospital
NCT07045467 Phase 1
Recruiting
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Chronic Kidney Diseases
NCT07271849 Phase 4
Recruiting
Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients
Postoperative Pain, Acute
NCT05339568
Recruiting
Patient's Whole Process Follow-up Management(HOPE-1)
Locally Advanced Non-Small Cell Lung Cancer
NCT07530770
Recruiting
Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
NCT06043973 Phase 3
Recruiting
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Advanced Non-small Cell Lung Cancer
NCT07611838
Recruiting
Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction
Allergic Bronchopulmonary Aspergillosis (ABPA)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology